{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"8.360","floor":"6.360"},"ipodate":{"start":"2016-12-30 00:00:00","end":"2017-01-11 00:00:00"},"minimumcapital":"4222.13","subscribed":"1.23","marketcap":"35.33億","H_marketcap":"--","pe":"12.63","codesrate":"100.00","link":"https://staticpdf.iqdii.com/stockdata/notice/Prospectus/01518/LTN20161230040_C.pdf","ipopricing":"7.360","resultdate":"2017-01-17 00:00:00","enddate":"2017-01-11 00:00:00","listeddate":"2017-01-18 00:00:00","issuenumber":"12000.00萬","issuenumberhK":"1200.00萬","issuenumberother":"10800.00萬","grayprice":"7.70","sponsors":"美林遠東有限公司,中國國際金融香港證券有限公司","raisemoney":"78870.00萬","use":"1、39.4百萬港元（相當于所得款項凈額的5.0%）將用于在北京興建一座遠程醫療診斷中心；\n2、39.4百萬港元（相當于所得款項凈額的5.0%）將用于翻新及提升我們于北京的一間手術中心；\n3、157.7百萬港元（相當于所得款項凈額的20.0%）將用于在北京開設一家新醫院以提供專業兒科及婦產科服務以及在北京開設兩家診所以主要提供門診服務；\n4、157.7百萬港元（相當于所得款項凈額的20.0%）將用于在北京以外的一線城市開設一間新醫院及兩間診所；\n5、315.5百萬港元（相當于所得款項凈額的40.0%）將用于收購一線城市（包括北京）的一間醫院及五間診所；\n6、78.9百萬港元（相當于所得款項凈額的10.0%）將用作營運資金及其他一般公司用途。","shares":500,"leadagent":"美林遠東有限公司,中國國際金融香港證券有限公司,中銀國際亞洲有限公司,招商證券(香港)有限公司","bookrunners":"美林遠東有限公司,中國國際金融香港證券有限公司,中銀國際亞洲有限公司,招商證券(香港)有限公司","coordinator":"美林遠東有限公司,中國國際金融香港證券有限公司","firstDayOpen":"7.50","IsEiio":0,"Interestdays":6,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"中國國際金融香港證券有限公司","code":"E01518","name":"新世紀醫療","fullname":"新世紀醫療控股有限公司"},"institutioninfo":{"principaloffice":"中國北京市西城區南禮士路56號","registrars":"香港中央證券登記有限公司","registrarstel":"(852) 2862 8628","chairman":"Jason ZOU","secretary":"賈曉鋒","telephone":"(010) 5178 3369","substantialshareholders":"Jason Zhou(44.12%),梁艷清(11.78%),中國再保險(集團)股份有限公司(6.59%),安怡和康(天津)投資合伙企業(有限合伙)(6.44%),上海孚紀投資合伙企業(有限合伙)(6.09%),上海孚怡投資合伙企業(有限合伙)(6.09%)","principalactivities":"提供兒科及婦產科專科服務，以及提供醫院諮詢服務。","website":"http://www.ncich.com.cn"},"managerinfo":[{"managername":"Jason ZHOU","post":"董事長、首席執行官兼執行董事","rankno":1},{"managername":"辛紅","post":"副總裁、首席運營官兼執行董事","rankno":2},{"managername":"徐瀚","post":"副總裁、首席財務官兼執行董事","rankno":3}],"investorinfo":[{"institutionname":"中國人壽再保險有限責任公司","shareholding":"31,609,000.0","percentage":6.59,"ReleaseDate":"2017-07-18 00:00:00","relatedparty":"中國再保險(集團)股份有限公司","subsidiary":["中國人壽再保險有限責任公司"],"InverstorType":"公司"},{"institutionname":"CNCB (Cayman) NCH LP","shareholding":"23,900,000.0","percentage":4.98,"ReleaseDate":"2017-07-18 00:00:00","relatedparty":"CNCB (Cayman) Bright Limited","subsidiary":["CNCB (Cayman) NCH LP"],"InverstorType":"基金"},{"institutionname":"Janchor Partners Pan-Asian Master Fund","shareholding":"21,072,500.0","percentage":4.39,"ReleaseDate":"2017-07-18 00:00:00","relatedparty":"Janchor PartnersLimited","subsidiary":["Janchor Partners Pan-Asian Master Fund"],"InverstorType":"基金"}],"TotalShareholdingPercentage":15.96},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":524}